XYLB — XY Labs Balance Sheet
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- $9.73m
- $7.78m
- $13.17m
Annual balance sheet for XY Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 0.59 | 0.377 | 0.4 | 3.9 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 2.27 | 1.32 | 0.614 | 3.04 |
| Total Inventory | ||||
| Total Current Assets | 4.31 | 2.14 | 1.45 | 7.48 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.196 | 0.348 | 0.193 | 0.149 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 8.41 | 2.73 | 1.76 | 8.53 |
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 4.55 | 3.35 | 4.12 | 6.81 |
| Long Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 4.83 | 3.46 | 5.66 | 7.32 |
| Non Redeemable Preferred Stock | ||||
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Total Equity | 3.59 | -0.725 | -3.89 | 1.21 |
| Total Liabilities & Shareholders' Equity | 8.41 | 2.73 | 1.76 | 8.53 |
| Total Common Shares Outstanding |